Advanced Micro- and Nanofluidics Revolutionizing the Point of Care Diagnostic Industry

Advanced Micro- and Nanofluidics Revolutionizing the Point of Care Diagnostic Industry

Disruptive microfluidic technologies enabling decentralization of diagnostic tests

RELEASE DATE
15-Apr-2021
REGION
Global
Research Code: D9EB-01-00-00-00
SKU: HC03407-GL-TR_25371

$4,950.00

Special Price $4,455.00 save 10 %

In stock
SKU
HC03407-GL-TR_25371

$4,950.00

$4,455.00 save 10 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achieving higher throughput. This research explores the advantages and challenges of traditional as well as emerging materials and fabrication technologies for the point-of-care applications. Various nanofluidic phenomena being investigated for point-of-care diagnosis is also reported. The report also covers some of the remarkable innovations in different segments of the industry, and also lists OEM manufacturing companies supporting innovations in the field. The drivers and challenges of the microfluidics and nanofluidics-based point-of-care diagnostics industry are explored in detail. Notable funding and acquisition activities in the last three years are also investigated. The growth opportunities offered by autonomous microfluidic devices, 3D printing, flexible microfluidics and integration with information technologies are discussed. Strategic recommendations to succeed in the space are also put forth. In addition to the above, this research service also offers insights on the IP landscape and the key patents in the last six years.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

1.1 The Strategic Imperative 8™

1.1 The Strategic Imperative 8™ (Continued)

1.2 The Impact of the Top Three Strategic Imperatives on the Microfluidics- and Nanofluidics-based Point of Care Diagnostics Industry

1.3 About the Growth Pipeline Engine ™

1.4 Growth Opportunities Fuel the Growth Pipeline Engine™

2.1 Scope of the Research

2.2 Research Methodology

2.2 Research Methodology (Continued)

3.1 Microfluidics and Nanofluidics Scale down a Laboratory onto a Chip

3.2 Microfluidics Offers a Multitude of Benefits for Life Science Studies and Medical Devices

3.3 Point-of-Care Diagnostic Tests Enable Better Patient Outcomes

3.4 Near Patient-Diagnosis at Several Point-of-Care Settings Has Become a Necessity

3.5 Microfluidics Can Enable Point-of-Care Diagnosis and Personalized Medicine

3.6 Materials for the Microfluidic Platforms Are Selected Based on the Application

3.7 Polymers are the Most Commonly Used Materials in Microfluidics

3.8 Hydrogels Are Emerging Materials for Point-of-Care Platforms

3.9 The Choice of Fabrication Technique Depends on the Material and Design of the Platform

3.10 3D Printing is an Emerging Fabrication Technology for Production of Low-cost Microfluidic Chips

3.11 Microfluidic Manufacturing Companies Support Device Developers in Device Design, Development, and Manufacturing

3.12 Technology Segmentation: Microfluidic Platforms Are Being Utilized in Diverse Point-of-Care Diagnostics

3.13 Nanofluidics Phenomena in Point-of-Care Diagnostics

4.1 Impact Mapping of Growth Drivers of the Microfluidics and Nanofluidics-based Point of Care Diagnostics Industry

4.2 Increase in Incidence of Infectious and Chronic Diseases will Drive the Microfluidics-based Point of Care Diagnostics Industry

4.3 Advances in Microfluidic and Sensor Technologies will Drive the Industry

4.4 Impact Mapping of Growth Challenges of the Microfluidics and Nanofluidics-based Point of Care Diagnostics Industry

4.5 Competition from Other Point of Care Platforms is a Major Challenge for the Industry

4.6 Fabricating Commercial Scale Complex and Integrated Microfluidic Devices is Difficult

4.7 Decentralization of Healthcare Enables the Growth of the Microfluidics-based Point of Care Diagnostics Industry

5.1.1 Microfluidic Point of Care Diagnostic System for Dry Eye Disease

5.1.2 Microfluidic Cartridges Enable Measurement of Critical Clinical Chemistry Parameters at Patient’s Bedside

5.2.1 Point of Care Complete Blood Count System

5.2.2 Cell Enumeration Platforms Enable Complete Blood Count Tests at the Point of Care

5.3.1 Hand-held Reader and Microfluidic Panels for Immunoassays

5.3.2 Microfluidic Immunoassay Platforms Enable Rapid Detection of Infectious and Chronic Diseases

5.4.1 MicroPCR Enabling On-site Screening of COVID-19

5.4.2 Microfluidic PCR Platforms Enable Rapid and Accurate Identification of the Pathogen

6.1 Microfluidics Enabling the Shift to Personalized Medicine

6.2 Growth Opportunity 1: Self-contained Microfluidic Devices to Enable Expanded Scope of POC Diagnostics

6.2 Growth opportunity 1: Self-contained Microfluidic Devices to Enable Expanded Scope of POC Diagnostics (Continued)

6.3 Growth Opportunity 2: 3D Printing to Enable Low-cost Disposable Point of Care Devices

6.3 Growth Opportunity 2: 3D Printing to Enable Low-cost Disposable Point of Care Devices (Continued)

6.4 Growth Opportunity 3: Flexible Microfluidics to Enable Real-time Assessment of Health

6.4 Growth Opportunity 3: Flexible Microfluidics to Enable Real-time Assessment of Health (Continued)

6.5 Growth Opportunity 4: Integration with Communication Technologies to Enable eHealth Diagnostics

6.5 Growth Opportunity 4: Integration with Communication Technologies to Enable eHealth Diagnostics (Continued)

6.6 Key Funding and Acquisition Activities in Microfluidic-based POC Diagnostic Devices

6.7 Key Conclusions and Strategic Recommendations

7.1 Increasing IP Activity Indicates Growing Interest in Microfluidic Point of Care Diagnosis

7.2 Key Patents to Check

7.2 Key Patents to Check (continued)

7.2 Key Patents to Check (continued)

8.1 Database of Key Industry Participants

Legal Disclaimer

Related Research
Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achieving higher throughput. This research explores the advantages and challenges of traditional as well as emerging materials and fabrication technologies for the point-of-care applications. Various nanofluidic phenomena being investigated for point-of-care diagnosis is also reported. The report also covers some of the remarkable innovations in different segments of the industry, and also lists OEM manufacturing companies supporting innovations in the field. The drivers and challenges of the microfluidics and nanofluidics-based point-of-care diagnostics industry are explored in detail. Notable funding and acquisition activities in the last three years are also investigated. The growth opportunities offered by autonomous microfluidic devices, 3D printing, flexible microfluidics and integration with information technologies are discussed. Strategic recommendations to succeed in the space are also put forth. In addition to the above, this research service also offers insights on the IP landscape and the key patents in the last six years.--BEGIN PROMO--

Microfluidics which involve manipulation of small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achieving higher throughput. Therefore, microfluidic-based point-of-care diagnostic devices can improve accessibility, affordability and accuracy of diagnostic tests, thus enabling rapid clinical decisions at several point-of-care settings, and better disease management leading to enhanced clinical outcomes. Several nanofluidic phenomena such as single nanopores, nanoporous membranes, nanoconfinement and concentration polarization are also being explored and exploited for point of care diagnosis. Microfluidic platforms for disease diagnosis are being used for analyzing and measuring analytes such as metabolites and small molecules, number of target cells, antigens and antibodies, and nucleic acids. While the increasing incidence of diseases, increased interest in personalized healthcare, technological advancements, the higher accuracy of microfluidic platforms compared to other POC platforms are driving the industry forward, the higher cost, requirement of expertise and fabrication complexity are challenging the growth. Advances in microfluidic platforms are rapidly decentralizing healthcare especially during COVID-19, and soon to enable a paradigm shift towards personalized medicine with the help of the development of epidermal microfluidic platforms. This research service (RS) explores the emerging microfluidic and nanofluidic technologies employed for point-of-care diagnosis of health status and diseases. This RS covers the advantages and challenges of traditional as well as emerging materials and fabrication technologies for the point-of-care applications. Various nanofluidic phenomena being investigated for point-of-care diagnosis is also reported. The report also covers some of the remarkable innovations in different segments of the industry, and also lists OEM manufacturing companies supporting innovations in the field. The drivers and challenges of the microfluidics and nanofluidics-based point-of-care diagnostics industry are explored in detail. Notable funding and acquisition activities in the last three years are also investigated. The growth opportunities offered by autonomous microfluidic devices, 3D printing, flexible microfluidics and integration with information technologies are discussed. Strategic recommendations to succeed in the space are also put forth. In addition to the above, this research service also offers insights on the IP landscape and the key patents in the last six years.  

More Information
No Index No
Podcast No
Author Sneha Maria Mariawilliam
Industries Healthcare
WIP Number D9EB-01-00-00-00
Is Prebook No